1. Home
  2. CNX vs ICUI Comparison

CNX vs ICUI Comparison

Compare CNX & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNX Resources Corporation

CNX

CNX Resources Corporation

HOLD

Current Price

$41.99

Market Cap

5.5B

Sector

Energy

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$126.71

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNX
ICUI
Founded
1860
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
3.9B
IPO Year
1998
1995

Fundamental Metrics

Financial Performance
Metric
CNX
ICUI
Price
$41.99
$126.71
Analyst Decision
Sell
Buy
Analyst Count
9
5
Target Price
$35.78
$182.25
AVG Volume (30 Days)
1.9M
266.1K
Earning Date
04-30-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
763.33
100.62
EPS
3.98
0.03
Revenue
$2,239,134,000.00
$2,231,262,000.00
Revenue This Year
$0.27
N/A
Revenue Next Year
$9.90
$4.46
P/E Ratio
$10.58
$4,195.00
Revenue Growth
76.76
N/A
52 Week Low
$27.68
$107.02
52 Week High
$43.62
$160.29

Technical Indicators

Market Signals
Indicator
CNX
ICUI
Relative Strength Index (RSI) 59.97 31.09
Support Level $36.33 $121.49
Resistance Level $43.62 $136.39
Average True Range (ATR) 1.49 5.48
MACD 0.00 -1.92
Stochastic Oscillator 76.62 9.13

Price Performance

Historical Comparison
CNX
ICUI

About CNX CNX Resources Corporation

CNX Resources Corp is an independent low carbon intensity natural gas and midstream company engaged in the exploration, development, production and acquisition of natural gas properties in the Appalachian Basin. The company's operating segment include Shale and Coalbed Methane. It generates maximum revenue from the Shale segment. It also has other segment that includes nominal shallow oil and gas production.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: